ArticleCancers2022

IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model.

Xiaoze Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.